Non small cell lung cancer patients with EGFR mutation : therapeutic sequences in a real life setting

被引：0
|
作者：
Berardi, G. [1 ]
Girard, N. [2 ]
De Fraipont, F. [3 ]
Decroisette, C. [4 ]
Gazzerie, S. [5 ]
Sibilot, D. Moro [1 ]
Toffart, A. C. [1 ]
机构：
[1] CHU Grenoble Alpes, Serv Pneumol & Physiol Resp, Grenoble, France
[2] Inst Thorax Curie Montsouris, Serv Pneumol, Paris, France
[3] CHU Grenoble Alpes, Serv Biol & Pathol, Grenoble, France
[4] CH Annecy Genevois, Serv Pneumol, Annecy, France
[5] Univ Grenoble Alpes, Inst Avancee Biosci, Grenoble, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.2053
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2053
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Osimertinib for the treatment of patients with EGFR mutation-positive non-small cell lung cancer
    Alsharedi, M.
    Bukamur, H.
    Elhamdani, A.
    DRUGS OF TODAY, 2018, 54 (06) : 369 - 379
  • [42] EGFR Mutation Prevalence and Epidemiological Profile of Patients with Metastatic Nonsquamous Non Small Cell Lung Cancer
    Simoes, Maria Fernanda E.
    Mascarenhas, Eldsamira
    Reis, Tercia V.
    Mathias, Clarissa
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S590 - S590
  • [43] CLINICAL EXPERIENCE USE GEFITINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH A MUTATION EGFR
    Vozniy, Eduard
    Popov, Anatoly
    Galkin, Michail
    Astrakhankina, Tamara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1214 - S1214
  • [44] Osimertinib for treating Patients with EGFR Mutation-Positive non-small cell Lung Cancer
    Meinrenken, Susanne
    PNEUMOLOGIE, 2018, 72 (04): : 246 - 246
  • [45] Effect of chemotherapy on EGFR mutation status in Chinese non-small cell lung cancer patients
    Wang, J.
    Bai, H.
    Zhao, J.
    Wang, Z.
    Zhuo, W.
    Wu, M.
    Duan, J.
    Wang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Impact of afatinib dosing on safety and efficacy in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC) in a real-world setting
    Halmos, Balazs
    Tan, Eng-Huat
    Soo, Ross
    Cadranel, Jacques
    Lee, Min Ki
    Foucher, Pascal
    Hsia, Te-Chun
    Hochmair, Maximilian
    Griesinger, Frank
    Hida, Toyoaki
    Kim, Edward
    Melosky, Barbara
    Maerten, Angela
    Carcereny, Enric
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 160 - 161
  • [47] Real-Life Data of Osimertinib in Pretreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR T790M Mutation
    Alfaro Autor, C.
    Romero, A.
    Calvo De Juan, V.
    Franco, F.
    Sanchez Romero, E.
    Ortiz Cortes, N.
    Sanz Moreno, S.
    Rodriguez Festa, A.
    Serna Blasco, R.
    Barquin Del Romo, M.
    Provencio, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1036 - S1036
  • [48] EGFR mutation and p-EGFR expression in resected Non-Small Cell Lung Cancer
    Liu Wei
    McMillen, Elizabeth
    Ye Fei
    Li Guanghu
    Wu Yong
    Yin Guanghao
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S916 - S916
  • [49] Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation
    Auliac, Jean Bernard
    Perol, Maurice
    Planchard, David
    Monnet, Isabelle
    Wislez, Marie
    Doubre, Helene
    Guisier, Florian
    Pichon, Eric
    Greillier, Laurent
    Mastroianni, Benedicte
    Decroisette, Chantal
    Schott, Roland
    Le Moulec, Sylvestre
    Arrondeau, Jennifer
    Cortot, Alexis B.
    Geriniere, Laurence
    Renault, Aldo
    Daniel, Catherine
    Falchero, Lionel
    Chouaid, Christos
    LUNG CANCER, 2019, 127 : 96 - 102
  • [50] Effects of metformin on a non-small cell lung cancer cell line with an EGFR mutation
    Kitazono, Satoru
    Takiguchi, Yuichi
    Ashinuma, Hironori
    Kitazono, Miyako
    Kitamura, Atsushi
    Tada, Yuji
    Kurosu, Katushi
    Sakaida, Emiko
    Sekine, Ikuo
    Tatsumi, Koichiro
    CANCER RESEARCH, 2012, 72
12345